Literature DB >> 24892788

Refractory absence epilepsy and glut1 deficiency syndrome: a new case report and literature review.

Francesca Ragona1, Sara Matricardi1, Barbara Castellotti2, Mara Patrini1, Elena Freri1, Simona Binelli3, Tiziana Granata1.   

Abstract

We report a 12-year-old female patient with a mild phenotype of glucose transporter type 1 deficiency syndrome (Glut1D). The clinical picture was characterized by refractory absence epilepsy, migraine, and learning disabilities. Absence seizures appeared at the age of 4 years, and electroencephalogram (EEG) showed irregular discharges of diffuse epileptic abnormalities. During the follow-up, seizures became drug resistant, cognitive evaluation revealed learning difficulties, and the patient complained migraine episodes. The evidence of seizure worsening before meals and the drug resistance suggested a Glut1D. Molecular analysis of SLC2A1 gene showed the presence of a pathogenic de novo mutation of the gene in heterozygosity (p.Ala275Thr, c.823G > A). Our case and the review of literature data on patients with Glut1D and absences provide a combination of clinical and EEG keys that should prompt the genetic analysis. The Glut1D should be suspected when absence seizures are associated with at least one among: irregular ictal EEG discharges, mild mental retardation, migraine, microcephaly, drug resistance, and worsening during fasting. An early diagnosis allows to establish one of the available ketogenic regimens which could modify the natural history of this treatable condition. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24892788     DOI: 10.1055/s-0034-1378130

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  6 in total

Review 1.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

Review 2.  Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency.

Authors:  Armond Daci; Adnan Bozalija; Fisnik Jashari; Shaip Krasniqi
Journal:  Int J Mol Sci       Date:  2018-01-05       Impact factor: 5.923

3.  Overall cognitive profiles in patients with GLUT1 Deficiency Syndrome.

Authors:  Valentina De Giorgis; Silvia Masnada; Costanza Varesio; Matteo A Chiappedi; Martina Zanaboni; Ludovica Pasca; Melissa Filippini; Joyce A Macasaet; Marialuisa Valente; Cinzia Ferraris; Anna Tagliabue; Pierangelo Veggiotti
Journal:  Brain Behav       Date:  2019-02-04       Impact factor: 2.708

4.  Diagnostic Challenges Associated with GLUT1 Deficiency: Phenotypic Variabilities and Evolving Clinical Features.

Authors:  Hyuna Kim; Jin Sook Lee; Youngha Lee; Soo Yeon Kim; Byung Chan Lim; Ki Joong Kim; Murim Choi; Jong Hee Chae
Journal:  Yonsei Med J       Date:  2019-12       Impact factor: 2.759

5.  The effect of chronic neuroglycopenia on resting state networks in GLUT1 syndrome across the lifespan.

Authors:  Anna Elisabetta Vaudano; Sara Olivotto; Andrea Ruggieri; Giuliana Gessaroli; Francesca Talami; Antonia Parmeggiani; Valentina De Giorgis; Pierangelo Veggiotti; Stefano Meletti
Journal:  Hum Brain Mapp       Date:  2019-11-11       Impact factor: 5.038

Review 6.  Therapeutic Options for Childhood Absence Epilepsy.

Authors:  Victoria Elisa Rinaldi; Giuseppe Di Cara; Elisabetta Mencaroni; Alberto Verrotti
Journal:  Pediatr Rep       Date:  2021-12-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.